Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: The importance of lung exclusion

Massimo Cugno, Jürg Nussberger, Paolo Biglioli, Francesco Alamanni, Raffaella Coppola, Angelo Agostoni

Research output: Contribution to journalArticle

Abstract

Study objectives: Hemodynamic complications including hypotensive episodes are frequently associated with cardiopulmonary bypass (CPB) and can be attributed to a generalized inflammatory response in which bradykinin may be a mediator. The purpose of this study was to determine the plasma levels of bradykinin-(1-9)nonapeptide in patients during CPB and the physiologic elimination of bradykinin by the lungs. Design: Prospective, observational study. Setting: University hospital, cardiac surgery unit. Patients and methods: Intra-arterial BP was monitored and serial blood samples were obtained from 27 patients undergoing CPB for cardiac surgery. We measured plasma bradykinin and parameters of coagulation, fibrinolysis, complement, contact system, and the cytokine tumor necrosis factor (TNF). Results: Mean arterial pressure fell progressively until the end of CPB (- 18 mm Hg, p = 0.001) but returned to baseline by the end of surgery. The venous bradykinin level, normal in basal conditions (median, 1.90 fmol/mL), was increased (p = 0.001) from 15 min after the beginning of CPB (5.71 fmol/mL) to the end of the operation (7.07 fmol/mL), with a peak at the end of CPB (9.81 fmol/mL; p = 0.0001); it was normal at recovery 24 h later (2.81 fmol/mL). Bradykinin plasma levels fell 60% across the lung when the pulmonary circulation was fully restored while the patients were still receiving CPB. Activated-factor XII, thrombin-antithrombin complexes, prothrombin fragment F1 + 2, plasmin-antiplasmin complexes, C3a, and TNF increased significantly after the beginning of the surgical procedure, rising further during CPB, and remained elevated until the end of surgery, but they all returned to normal within 24 h. Changes in plasma bradykinin levels were not correlated with any of the other variables. Conclusions: During CPB, there is a progressive increase of plasma bradykinin that is at least partially due to reduced catabolism as a consequence of shunting the lungs. The increase in bradykinin may contribute to the fall in BP.

Original languageEnglish
Pages (from-to)1776-1782
Number of pages7
JournalChest
Volume120
Issue number6
DOIs
Publication statusPublished - 2001

Keywords

  • Angiotensin-converting enzyme
  • Bradykinin metabolism
  • Coagulation
  • Complement
  • Extracorporeal circulation
  • Fibrinolysis
  • Hypotension

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: The importance of lung exclusion'. Together they form a unique fingerprint.

  • Cite this